Italy· 015228012
NOZINAN*20 cpr rivestite 25 mg
A levomepromazine product containing levomepromazina, registered in Italy by NEURAXPHARM ITALY SpA, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Levomepromazine is registered in 16 of 19 countries.
Countries holding a registration under ATC N05AA02 (levomepromazine), each read from that country’s own register.
- This record: Italy
- 8 of them publish a price we can compare per daily dose
Levomepromazine · ATC N05AA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of levomepromazine costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.30 in Italy to $6.20 in Switzerland — a ×4.8 gap.
- Italy: $1.30 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Levomepromazine · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.20
- IT Italy$1.30
The record
At a glance
- Active substance
- Levomepromazina
- Manufacturer
- NEURAXPHARM ITALY SpA
- Country
- Italy (IT)
- ATC code
- N05AA02
- ATC class
- Levomepromazine
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic015228012NOZINAN*20 cpr rivestite 25 mgEUR 2.58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
349 interactions on record for levomepromazine.
Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levomepromazine · interactions on record
349 records
- 44 severe
- 263 moderate
- 8 minor
Most severe, free to view
- MetoclopramideA03FA01severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
34 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levomepromazine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLevinan 6mg tabletsKyowa Kirin Ltd
- FinlandLevomepromazine AspireAspire Pharma (Malta) Limited
- FranceNOZINAN 100 mg, comprimé pelliculé sécableCRISTERS
- GermanyLevomepromazin AspireAspire Pharma (Malta) Limited
- NorwayLevomepromazin neuraxpharmNeuraxpharm
- SwitzerlandNozinan 100 mg, FilmtablettenNeuraxpharm Switzerland AG
- CanadaMETHOPRAZINEAA PHARMA INC
- SwedenLevomepromazine Aspire 100 mg TablettAspire Pharma (Malta) Limited
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Nozinan
- Belgium · Nozinan
- Czechia · Tisercin
- Germany · Levomepromazin Aspire, Levomepromazin Neuraxpharm
- Denmark · Levomepromazine Aspire
- Estonia · Levomepromazine Orion
- Spain · Sinogan
- Finland · Levomepromazine Aspire, Levomepromazine Orion
- France · Nozinan
- United Kingdom (Northern Ireland) · Levomepromazine Hydrochloride Wockhardt Uk, Levomepromazine Maleate Morningside Healthcare
- Greece · Nozinan
- Croatia · Nozinan
- Hungary · Tisercin
- Ireland · Nozinan
- Lithuania · Tisercin
- Luxembourg · Nozinan
- Latvia · Tisercin
- Netherlands · Nozinan
- Norway · Levomepromazine Aspire, Levomepromazine Orion
- Poland · Levomentis, Tisercin
- Portugal · Nozinan
- Romania · Levomepromazin Aspire, Levomepromazin Terapia
- Sweden · Levomepromazine Aspire, Levomepromazine Orion
- Slovakia · Tisercin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ac5d597-81c6-49d2-ba4d-de46e72e9193 GET /v1/drugs/3ac5d597-81c6-49d2-ba4d-de46e72e9193?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 2.58,
"source": "aifa",
"currency": "EUR",
"strength": "LEVOMEPROMAZINA 25MG 20 UNITA' USO ORALE",
"substance": "Levomepromazina",
"equivalence_group": "O0B",
"transparency_flag": null
}See everything about levomepromazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.